134419-44-6

Basic information

• Product Name: Benzoic acid, 2-hydroxy-5-iodo-3-methoxy-, methyl ester
• CAS NO: 134419-44-6
• Molecular Formula: C9H9IO4
• Molecular Weight: 308.073
• Mol File: 134419-44-6.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 2-hydroxy-5-iodo-3-methoxy-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 2-hydroxy-5-iodo-3-methoxy-, methyl ester(134419-44-6)
• EPA Substance Registry System: Benzoic acid, 2-hydroxy-5-iodo-3-methoxy-, methyl ester(134419-44-6)

Safety Data

• Hazardous Substances Data: 134419-44-6(Hazardous Substances Data)

Upstream product

• 877-22-5 3-methoxysalicylic acid 
• 6342-70-7 3-methoxymethylsalicylate 

Downstream Products

• 146444-96-4 2-(2-Fluoro-ethoxy)-5-iodo-3-methoxy-benzoic acid methyl ester 
• 171805-85-9 methyl 5-iodo-2,3-dimethoxybenzoate 
• 193882-82-5 methyl 2-ethoxy-5-iodo-3-methoxybenzoate 
• 1056028-67-1 (2S,3S,4R,5R,6R)-2,3-bis-benzyloxy-5-(3,4,5-tris-benzyloxy-6-benzyloxymethyltetrahydropyran-2-yl)benzoic acid 
• 1056028-66-0 (2S,3S,4R,5R,6R)-2,3-bis-benzyloxy-5-(3,4,5-trisbenzyloxy-6-benzyloxymethyltetrahydropyran-2-yl)benzoic acid methyl ester 
• 1175558-87-8 benzyloxy-5-benzyloxy-β-D-glucosyl-3,4-benzyloxysalicylate 
• 1056028-64-8 2,3-bis-benzyloxy-5-iodobenzoic acid methyl ester 
• 1056028-65-9 (2S,3S,4R,5R,6R)-2,3-bis-benzyloxy-5-(3,4,5-triacetoxy-6-acetoxymethyltetrahydropyran-2-yl)benzoic acid methyl ester 
• 1056028-63-7 2,3-dihydroxy-5-iodobenzoic acid methyl ester 
• 146445-07-0 (R)-(-)-2,3-dimethoxy-5-iodo-N-(2-pyrrolidinylmethyl)benzamide 
• 146445-06-9 5-Iodo-2,3-dimethoxy-N-((R)-1-trityl-pyrrolidin-2-ylmethyl)-benzamide 
• 171805-81-5 2-(2-Fluoro-ethoxy)-5-iodo-3-methoxy-benzoyl chloride 
• 146444-97-5 2-(2-fluoroethoxy)-5-iodo-3-methoxybenzoic acid 
• 193882-83-6 5-iodo-3-methoxy-2-(2-propenyloxy)benzoic acid 

Relevant articles and documents

A Salmochelin S4-Inspired Ciprofloxacin Trojan Horse Conjugate

A novel ciprofloxacin-siderophore Trojan Horse antimicrobial was prepared by incorporating key design features of salmochelin, a stealth siderophore that evades mammalian siderocalin capture via its glycosylated catechol units. Assessment of the antimicro

Synthesis and 5-HT-3 receptor binding activity of 5-[125I]iodo-2,3-dimethoxy-N-(1-azabicyclo[2.2.2]oct-3-yl]benzamide and its 5-halogen-2-alkoxyl homologues

(S)-5-Iodo-2,3-dimethoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide (MIZAC) was prepared from 5-iodo-2,3-dimethoxybenzoyl chloride and (S)-3-aminoquinuclidine. [125I]Iodode-stannylation of its corresponding 5-tri-n-butyltin derivative gave [125I]-MIZAC at 1800 Ci/mmol. Binding of [125I]-MIZAC in rat entorhinal cortex revealed a K(D) of 1.37 ± 0.21 nM. A series of racemic 2-O-alkyl derivatives of MIZAC were prepared and 5-HT-3 receptor affinities were determined by inhibition of [125I]-MIZAC binding. Optimal affinity for the receptor was obtained with small, electron-withdrawing substituents in the aromatic 5-position and with bulky substituents in the 3-position. [125I]-MIZAC is a selective radioligand useful for in vitro identification of the 5-HT-3 receptor.

Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT

A novel series of dual-labeling D2 dopamine agents (labeled with either 18F or 123I for PET or SPECT imaging, respectively) was investigated. Two desired fluorinated and iodinated dopamine agents, FIDA1, (S)-(-)-2-(2- fluoroethoxy)-5